Skip to main content
Equibles

Equitable Holdings, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1333986 NEW YORK, NY
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,089,324
-$323,834 QoQ
Shares Held
1,747
-4.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#631
of 1,329 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Equitable Holdings, Inc. holds $9,067,537 across 15 Biotechnology names. REGN ranks #3 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 9,304 $2,940,901
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,920 $1,450,451
3 REGN
Regeneron Pharmaceuticals, Inc.
This page 		1,747 $1,089,324
4 RVMD
Revolution Medicines, Inc.
 5,140 $962,619
5 CRSP
CRISPR Therapeutics AG
 16,341 $891,238
6 VKTX
Viking Therapeutics, Inc.
 11,000 $429,110
7 EXEL
Exelixis, Inc.
 7,495 $407,802
8 JAZZ
Jazz Pharmaceuticals plc
 1,304 $314,224

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,089,324 1,747
2026-03-31 $1,413,158 1,829
2025-12-31 $930,103 1,205
2025-09-30 $473,431 842
2025-06-30 $462,525 881
2025-03-31 $586,662 925
2024-12-31 $633,261 889
2024-09-30 $1,162,671 1,106
2024-06-30 $1,129,857 1,075
2024-03-31 $981,739 1,020
2023-12-31 $870,385 991
2023-09-30 $790,864 961
2023-06-30 $709,917 988
2023-03-31 $794,554 967
2022-12-31 $687,579 953
2022-09-30 $441,565 641
2022-06-30 $400,786 678
2022-03-31 $504,957 723
2021-09-30 $277,172 458